ASCO supports government report: "Off-label drugs: reimbursement policies constrain physicians in choice of cancer therapies".
D000970:Antineoplastic Agents / Q000191:economics*; D008495:Medical Oncology; D006278:Medicare; D010818:Practice Patterns, Physicians' / Q000191:economics*; D012051:Reimbursement Mechanisms; D012955:Societies, Medical; D014481:United States
D000970:Antineoplastic Agents